DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 178, Issue 1, Pages R19-R31
Publisher
Bioscientifica
Online
2017-10-19
DOI
10.1530/eje-17-0585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone Turnover Markers: Use in Fracture Prediction
- (2017) Tatiane Vilaca et al. JOURNAL OF CLINICAL DENSITOMETRY
- Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation
- (2017) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
- (2017) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
- (2017) P. Szulc et al. OSTEOPOROSIS INTERNATIONAL
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis
- (2016) Kosuke Ebina et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data
- (2016) Katy JL Bell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause
- (2016) Albert Shieh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A retrospective analysis of nonresponse to daily teriparatide treatment
- (2016) R. Niimi et al. OSTEOPOROSIS INTERNATIONAL
- Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study
- (2016) E. A. Marques et al. OSTEOPOROSIS INTERNATIONAL
- Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia
- (2016) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- Postmenopausal osteoporosis
- (2016) Richard Eastell et al. Nature Reviews Disease Primers
- Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once-Yearly ZOL: HORIZON-PFT Extension Study
- (2015) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
- (2015) Pascale Chavassieux et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
- (2015) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture
- (2014) Helena Johansson et al. CALCIFIED TISSUE INTERNATIONAL
- PINP as a biological response marker during teriparatide treatment for osteoporosis
- (2014) J. H. Krege et al. OSTEOPOROSIS INTERNATIONAL
- Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
- (2014) Douglas C. Bauer et al. JAMA Internal Medicine
- BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate
- (2013) Brian Louis McNabb et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2013) Adolfo Díez-Pérez et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Adherence to raloxifene therapy: assessment methods and relationship with efficacy
- (2013) J. Finigan et al. OSTEOPOROSIS INTERNATIONAL
- An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide
- (2013) R. Niimi et al. OSTEOPOROSIS INTERNATIONAL
- Reference intervals of bone turnover markers in healthy premenopausal women: Results from a cross-sectional European study
- (2012) Richard Eastell et al. BONE
- Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)
- (2012) Yoshiki Nishizawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
- (2012) Richard M Jacques et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment failure in osteoporosis
- (2012) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Official Positions for FRAX® Clinical Regarding Biochemical Markers
- (2011) Eugene V. McCloskey et al. JOURNAL OF CLINICAL DENSITOMETRY
- PINP as an aid for monitoring patients treated with teriparatide
- (2010) Mika Tsujimoto et al. BONE
- Status of Hemoglobin A1c Measurement and Goals for Improvement: From Chaos to Order for Improving Diabetes Care
- (2010) R. R. Little et al. CLINICAL CHEMISTRY
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
- (2010) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands
- (2010) J. C. Netelenbos et al. OSTEOPOROSIS INTERNATIONAL
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
- (2009) Sarah J. Glover et al. BONE
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
- (2009) Pierre D Delmas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Establishing a reference range for bone turnover markers in young, healthy women
- (2008) S.J. Glover et al. BONE
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States
- (2008) Sarah J Glover et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Serial Assessment of Serum Bone Metabolism Markers Identifies Women with the Highest Rate of Bone Loss and Osteoporosis Risk
- (2008) Kaisa K. Ivaska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation